GAMMA Investing »

Aerovate Therapeutics shares owned by GAMMA Investing

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.8k 94 29.57
2023-12-31 $1.5k 80 19.31

More positions owned by GAMMA Investing

Microsoft Corp Common Stock (MSFT)
Nvidia Corporation Common Stock (NVDA)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Jpmorgan Chase Common Stock (JPM)
Meta Platforms Inc Cl A Common Stock (META)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Ishares Tr National Mun Etf Etf (MUB)
Visa Inc Com Cl A Common Stock (V)
Broadcom Common Stock (AVGO)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Ishares Inc Core Msci Emkt Etf (IEMG)
Eli Lilly Common Stock (LLY)
Home Depot Common Stock (HD)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)

View all positions for GAMMA Investing

Top funds holding Aerovate Therapeutics

RA Capital Management
Atlas Venture Life Science Advisors
Baker Bros. Advisors
Cormorant Asset Management
Frazier Life Sciences Management
Dr. Jeffrey R. Jay, M.D.
OrbiMed Advisors
Vanguard Group
Point72 Asset Management
Octagon Capital Advisors
Paradigm Biocapital Advisors
Hudson Bay Capital Management
Nantahala Capital Management
Fred Alger Management
Charles Schwab Investment Management

View all funds holding Aerovate Therapeutics